Mindset Pharma CEO says the firm’s recent efforts in the psychedelic space are delivering

Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) CEO James Lanthier takes Proactive through the company’s achievements of the past six months.

Lanthier said the biotech company’s efforts in the psychedelic space have begun to deliver impressive innovations, partnerships, and feedback reinforcing the its patent portfolio.

“We’ve shared a lot of positive news with the market in the last few months and we really wanted to take the opportunity to step back and really explain how it all fits into the big picture,” Lanthier said.

© 2022 Stockmark.it The Latest StockMarket News and Interviews